Management of neuropathic pain in children with cancer

Current Opinion in Supportive and Palliative Care

Volumn 7, Issue 2, 2013, Pages 131-138

  Friedrichsdorf, Stefan J ^a,b   Andrea Postier Nugent, ^a  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Neuropathic; Pain; Pediatric

Indexed keywords

ANALGESIC AGENT;

ANALGESIA; CHILD; HUMAN; METHODOLOGY; NEOPLASM; NEURALGIA; PAIN ASSESSMENT; PEDIATRICS; PRESCHOOL CHILD; REVIEW;

ANALGESICS; CHILD; CHILD, PRESCHOOL; HUMANS; NEOPLASMS; NEURALGIA; PAIN MANAGEMENT; PAIN MEASUREMENT; PEDIATRICS;

EID: 84877998706     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e3283615ebe     Document Type: Review

References (45)

1. Poder U, Ljungman G, von Essen L. Parents' perceptions of their children's cancer-related symptoms during treatment: a prospective, longitudinal study. J Pain Symptom Manage 2010; 40: 661-670.
2. Bennett MI, Rayment C, Hjermstad M, Aass N. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain 2012; 153: 359-365.
3. International Association for the Study of Pain. Available at: http://www. iasppain. org/AM/Template. cfm?Section=Pain-Definitions. (Accessed 28 January 2013)
4. Dougherty PM, Cata JP, Burton AW. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J Pain Symptom Manage 2007; 33: 166-179.
5. Pace A, Carpano S, Galie E. Vitamin E in the neuroprotection of cisplatininduced peripheral neurotoxicity and ototoxicity. J Clin Oncol (Meeting Abstracts) 2007; 25 (Suppl):abstr 9114.
6. Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain 1984; 18: 83-95.
7. Subedi B, Grossber G, Phantom Limb. Pain: Mechanisms, Treatment, Approaches, Pain Research, Treatment 2011. [Epub ahead of print]
8. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic. Neurology 1997; 48: 332-338.
9. MAPI Research Institute. Available at: http://www. mapi-research. fr/t-03- serv-dist-Cduse-nps. htm. (Accessed January 2013)
10. MAPI Research Institute. Available at: http://www. mapi-research. fr/t-03- serv-dist-Cduse-pqas. htm (Accessed January 2013)
11. von Baeyer CL, Spagrud LJ. Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years. Pain 2007; 127: 140-150.
12. Jay SM, Elliott CH, Katz E, Siegel SE. Cognitive-behavioral and pharmacologic interventions for childrens' distress during painful medical procedures. J Consult Clin Psychol 1987; 55: 860-865.
13. von Baeyer CL, Spagrud LJ, McCormick JC, Choo E. Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children's selfreports of pain intensity. Pain 2009; 143: 223-227.
14. von Baeyer CL. Children's self-reports of pain intensity: scale selection, limitations and interpretation. Pain Res Manag 2006; 11: 157-162.
15. Denecke H, Hünseler C. Messen und Erfassen von Schmerz. In: Schmerztherapie bei Kindern. Ed. 2. Edited by Zernikow B (editor). Berlin, Heidelberg: Springer; 2003. pp. 51-79.
16. von Baeyer CL. Children's self-report of pain intensity: what we know, where we are headed. Pain Res Manag 2009; 14: 39-45.
17. Friedrichsdorf S, Kuttner, L, Westendorp K, McCarty R. Integrative Pediatric Palliative Care. In: Integrative Pediatrics. Edited by Culbert, TP, Olness K (editors). New York: Oxford University Press; 2010 pp. 569-93.
18. Finnerup NB, Otto M, McQuay HJ. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289-305.
19. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-581.
20. Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev 2006; CD006146.
21. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2007; CD005454.
22. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005; CD005452.
23. Bamigbade TA, Langford RM. The clinical use of tramadol hydrochloride. Pain Rev 1998; 5: 155-182.
24. Rose JB, Finkel JC, Arquedas-Mohs A. Oral tramadol for the treatment of pain of 7-30 days' duration in children. Anesth Analg 2003; 96: 78-81.
25. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005; CD005452.
26. Moore RA, Straube S, Wiffen PJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009; CD007076..
27. Dix P, Martindale S, Stoddart PA. Double-blind randomized placebo-controlled trial of the effect of ketamine on postoperative morphine consumption in children following appendicectomy. Paediatr Anaesth 2003; 13: 422-426.
28. Wallace MS, Lee J, Sorkin L. Intravenous lidocaine: effects on controlling pain after anti-GD2 antibody therapy in children with neuroblastoma-a report of a series. Anesth Analg 1997; 85: 794-796.
29. Massey GV, Pedigo S, Dunn NL, et al. Continuous lidocaine infusion for the relief of refractory malignant pain in a terminally ill pediatric cancer patient. J Pediatr Hematol Oncol 2002; 24: 566-568.
30. Krane E, Leong M, Golianu B, Leong Y. Treatment of Pediatric Pain with Nonconventional Analgesics. In: Schechter N, Berde C, Yaster M, editors. Pain in infants, children, and adolescents. Philadelphia: Lippincott Williams & Wilkins; 2003. pp. 225-240.
31. Ferrini R, Paice JA. How to initiate and monitor infusional lidocaine for severe and/or neuropathic pain. J Support Oncol 2004; 2: 90-94.
32. Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol 2005; 168: 509-554.
33. Johanek LM, Simone DA. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by heat injury. Pain 2004; 109: 432-442.
34. Cichewicz DL. Synergistic interactions between cannabis and opioid analgesics. Life Sci 2004; 74: 1317-1324.
35. Vaughan CW, Christie MJ. An analgesic role for cannabinoids. Med J Aust 2000; 173: 270-272.
36. Herzberg U, Herzberg U, Eliav E. The analgesic effects of R(+)-WIN 55, 212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett 1997; 221: 157-160.
37. Williamson EM, Evans FJ. Cannabinoids in clinical practice. Drugs 2000; 60: 1303-1314.
38. Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005; 65: 812-819.
39. Meier MH, Caspi A, Ambler A, Harrington H. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A 2012; 109:E2657-E2664.
40. Simon T, Niemann CA, Hero B, Henze G. Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastoma. Dev Med Child Neurol 2012; 54: 347-352.
41. Anghelescu DL, Faughnan LG, Hankins GM. Methadone use in children and young adults at a cancer center: a retrospective study. J Opioid Manag 2011; 7: 353-361.
42. Kajiume T, Sera Y, Nakanuno R. Continuous intravenous infusion of ketamine and lidocaine as adjuvant analgesics in a 5-year-old patient with neuropathic cancer pain. J Palliat Med 2012; 15: 719-722.
43. Delavallee M, Rooijakkers H, Koerts G, Raftopoulos C. Motor cortex stimulation in a three-year-old child with trigeminal neuropathic pain caused by a malignant glioma in the cerebellopontine angle: case report. Neurosurgery 2011; 69:E494-E496.
44. Anghelescu DL, Oakes LL, Hankins GM. Treatment of pain in children after limb-sparing surgery: an institution's 26-year experience. Pain Manag Nurs 2011; 12: 82-94.
45. Anghelescu DL, Faughnan LG, Jeha S, Relling MV. Neuropathic pain during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2011; 57: 1147-1153.